| |
|
|
|
Plx Pharma Inc  
|
|
3.73 -0.18 (-0.05%) |
05-29 16:00 |
|
Open: |
4.08 |
Pre close: |
3.91 |
Target:
|
5.65
|
|
High: |
4.08 |
Low: |
3.4 |
Resistance:
|
4.84
5.65
|
|
Volume: |
44,498 |
Market Cap: |
34M |
Support:
|
3.28
2.31
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.77
 |
MACD |
MACD(12,26):
|
0.26 |
|
MA(20): |
2.98 |
Signal(12,26,9): |
0.11 |
|
MA(100): |
3.84  |
Stochastic Oscillator |
%K(14,3):
|
61.02 |
|
MA(250): |
4.70 |
%D(3): |
67.42 |
|
Average Volume(K) |
3-Month: |
1700
|
52-Week |
High:
|
7.41 |
|
10-Days: |
3447 |
Low: |
1.80 |
|
RSI |
RSI(14):
|
66.28 |
Change(%): |
-25.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.095 |
Return on Equity (ttm) |
-119.8 |
Shares Out. (M) |
9.15 |
|
EPS Est. Current Year |
-1.610 |
Return on Assets (ttm) |
-41.9 |
Shares Float (M) |
7.47 |
|
EPS Est. Next Year |
-1.820 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.30 |
|
EPS Est. Next Quarter |
-0.460 |
Qtrly Rev. Growth |
-99.2 |
% Held by Institutions |
22.44 |
|
Forward EPS |
-3.840 |
Gross Profit (p.s.) |
0.062 |
Shares Short (K) |
140 |
|
Book Value (p.s.) |
-1.160 |
EBITDA (p.s.) |
-1.546 |
P/E |
-3.41 |
|
Sales Per Share |
0.027 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-3.22 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.16 |
P/S |
136.28 |
|
Operating Margin |
-5705.31 |
Levered Free Cash Flow
(M) |
-7.73 |
P/CF |
-2.59 |
|
|
|
|
|
|
